|
NECAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.047000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.810000E-01 |
| Normal-vs-Stage2 |
3.534800E-01 |
| Normal-vs-Stage3 |
5.583000E-01 |
| Normal-vs-Stage4 |
6.495000E-01 |
| Stage1-vs-Stage2 |
3.184600E-01 |
| Stage1-vs-Stage3 |
4.408400E-01 |
| Stage1-vs-Stage4 |
6.087600E-01 |
| Stage2-vs-Stage3 |
6.075000E-01 |
| Stage2-vs-Stage4 |
7.178200E-01 |
| Stage3-vs-Stage4 |
9.985600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.558800E-01 |
| Normal-vs-AfricanAmerican |
3.625200E-01 |
| Normal-vs-Asian |
8.859400E-01 |
| Caucasian-vs-AfricanAmerican |
3.269200E-01 |
| Caucasian-vs-Asian |
9.661000E-01 |
| AfricanAmerican-vs-Asian |
7.509600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.955000E-01 |
| Normal-vs-Female |
4.305800E-01 |
| Male-vs-Female |
5.196400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.419400E-01 |
| Normal-vs-Extreme_Weight |
6.390600E-01 |
| Normal-vs-Obese |
8.464400E-01 |
| Normal-vs-Extreme_Obese |
4.653800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.610800E-01 |
| Normal_Weight-vs-Obese |
6.590200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.271200E-01 |
| Extreme_Weight-vs-Obese |
6.795000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.678000E-01 |
| Obese-vs-Extreme_Obese |
3.806600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.088000E-02 |
| Normal-vs-Age(41-60Yrs) |
4.280400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.424000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.837600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.825600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642050E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.795520E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.791560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.706620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.244000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.105200E-01 |
| Normal-VS-Type2 PRCC |
7.672600E-01 |
| Normal-VS-KIRP CIMP |
1.502370E-03 |
| Normal-VS-Unclassified PRCC |
1.751390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.768000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.967070E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.232600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.762700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.102200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.753800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.718000E-01 |
| Normal-vs-N1 |
7.002800E-01 |
| Normal-vs-N2 |
6.521000E-01 |
| N0-vs-N1 |
9.026400E-01 |
| N0-vs-N2 |
8.124600E-01 |
| N1-vs-N2 |
8.559400E-01 |
|
|
